{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T22:30:20Z","timestamp":1787610620095,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1038\/s41433-026-04331-5","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T13:16:59Z","timestamp":1771507019000},"page":"966-971","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Differentiation of macular atrophy secondary to neovascular age-related macular degeneration vs. de novo geographic atrophy: a multimodal analysis"],"prefix":"10.1038","volume":"40","author":[{"given":"Elham","family":"Sadeghi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"DeCicco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasiq","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"DiCenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica Ye","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Rahmanipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4831-1153","authenticated-orcid":false,"given":"Jose-Alein","family":"Sahel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6472-5460","authenticated-orcid":false,"given":"Andrew W.","family":"Eller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1772-3558","authenticated-orcid":false,"given":"Jay","family":"Chhablani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"key":"4331_CR1","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.ophtha.2013.11.023","volume":"121","author":"FG Holz","year":"2014","unstructured":"Holz FG, Strauss EC, Schmitz-Valckenberg S, van Lookeren Campagne M. Geographic atrophy: clinical features and potential therapeutic approaches. Ophthalmology. 2014;121:1079\u201391.","journal-title":"Ophthalmology"},{"key":"4331_CR2","unstructured":"Vajzovic L, Carolyn M. Unlocking Geographic Atrophy. Ophthalmology Times, Digital Edition. 2023;48."},{"key":"4331_CR3","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.ophtha.2011.09.027","volume":"119","author":"AR Rudnicka","year":"2012","unstructured":"Rudnicka AR, Jarrar Z, Wormald R, Cook DG, Fletcher A, Owen CG. Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: a meta-analysis. Ophthalmology. 2012;119:571\u201380.","journal-title":"Ophthalmology"},{"key":"4331_CR4","first-page":"257","volume":"17","author":"MM Brown","year":"2006","unstructured":"Brown MM, Brown GC, Sharma S, Stein JD, Roth Z, Campanella J, et al. The burden of age-related macular degeneration: a value-based analysis. Curr Opin Ophthalmol. 2006;17:257\u201366.","journal-title":"Curr Opin Ophthalmol"},{"key":"4331_CR5","doi-asserted-by":"crossref","unstructured":"Xu L, Mrejen S, Jung JJ, Gallego-Pinazo R, Thompson D, Marsiglia M, et al. Geographic atrophy in patients receiving anti-vascular endothelial growth factor for neovascular age-related macular degeneration. Retina. 2015;35:176\u201386.","DOI":"10.1097\/IAE.0000000000000374"},{"key":"4331_CR6","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.ophtha.2012.03.053","volume":"119","author":"DF Martin","year":"2012","unstructured":"Martin DF, Maguire MG, Fine SL, Ying G-s, Jaffe GJ, Grunwald JE, et al. Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results. Ophthalmology. 2012;119:1388\u201398.","journal-title":"Ophthalmology"},{"key":"4331_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/IAE.0b013e3182657fff","volume":"33","author":"N Lois","year":"2013","unstructured":"Lois N, Mcbain V, Abdelkader E, Scott NW, Kumari R. Retinal pigment epithelial atrophy in patients with exudative age-related macular degeneration undergoing anti\u2013vascular endothelial growth factor therapy. Retina. 2013;33:13\u201322.","journal-title":"Retina"},{"key":"4331_CR8","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1097\/IAE.0000000000001392","volume":"37","author":"DS Boyer","year":"2017","unstructured":"Boyer DS, Schmidt-Erfurth U, van Lookeren Campagne M, Henry EC, Brittain C. The pathophysiology of geographic atrophy secondary to age-related macular degeneration and the complement pathway as a therapeutic target. Retina. 2017;37:819\u201335.","journal-title":"Retina"},{"key":"4331_CR9","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41433-024-03463-w","volume":"39","author":"MU Jamil","year":"2025","unstructured":"Jamil MU, Waheed NK. Gene therapy for geographic atrophy in age-related macular degeneration: current insights. Eye. 2025;39:274\u201383.","journal-title":"Eye"},{"key":"4331_CR10","doi-asserted-by":"crossref","unstructured":"Pegcetacoplan (Syfovre) for geographic atrophy in age-related macular degeneration. Med Lett Drugs Ther. 2023;65:49-50.","DOI":"10.58347\/tml.2023.1673a"},{"key":"4331_CR11","doi-asserted-by":"crossref","unstructured":"Avacincaptad pegol (Izervay) for geographic atrophy in age-related macular degeneration. Med Lett Drugs Ther. 2024;66:15-6.","DOI":"10.58347\/tml.2024.1694d"},{"key":"4331_CR12","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/S0140-6736(23)01520-9","volume":"402","author":"JS Heier","year":"2023","unstructured":"Heier JS, Lad EM, Holz FG, Rosenfeld PJ, Guymer RH, Boyer D, et al. Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials. Lancet. 2023;402:1434\u201348.","journal-title":"Lancet"},{"key":"4331_CR13","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1007\/s40123-025-01144-9","volume":"14","author":"AHK Nissen","year":"2025","unstructured":"Nissen AHK, Torp TL, Vergmann AS. Clinical outcomes of treatment of geographic atrophy: a narrative review. Ophthalmol Ther. 2025;14:1173\u201381.","journal-title":"Ophthalmol Ther"},{"key":"4331_CR14","doi-asserted-by":"crossref","unstructured":"Rush RB, Klein W, Rush SW, Reinauer RM. Real-world outcomes in pre-existing neovascular age-related macular degeneration subjects undergoing avacincaptad therapy for geographic atrophy. Clin Ophthalmol. 2024;18:4011\u20138.","DOI":"10.2147\/OPTH.S497678"},{"key":"4331_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.22259\/2638-5120.0601001","volume":"6","author":"R Zubricky","year":"2025","unstructured":"Zubricky R, Miller C, Sciulli H, Coney J, Goduni L, Hull T, et al. Incidence of Recurrent choroidal Neovascularization Following treatment with Pegcetacoplan for Geographic atrophy in exudative age-Related Macular Degeneration Patients with Inactive choroidal Neovascularization. Arch Ophthalmol Optom. 2025;6:1\u20137.","journal-title":"Arch Ophthalmol Optom"},{"key":"4331_CR16","doi-asserted-by":"crossref","unstructured":"Grunwald JE, Pistilli M, Daniel E, Ying G-S, Jaffe GJ, Fine SL, et al. Size and growth of geographic atrophy during 5 years of follow up in the comparison of age-related macular degeneration treatments trials (CATT). Investig Ophthalmol Visual Sci. 2016;57.","DOI":"10.1016\/j.ophtha.2016.09.012"},{"key":"4331_CR17","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S0039-6257(05)80092-X","volume":"39","author":"A Bird","year":"1995","unstructured":"Bird A, Bressler N, Bressler S, Chisholm I, Coscas G, Davis M, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. Surv Ophthalmol. 1995;39:367\u201374.","journal-title":"Surv Ophthalmol"},{"key":"4331_CR18","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.ophtha.2017.09.028","volume":"125","author":"SR Sadda","year":"2018","unstructured":"Sadda SR, Guymer R, Holz FG, Schmitz-Valckenberg S, Curcio CA, Bird AC, et al. Consensus definition for atrophy associated with age-related macular degeneration on OCT: classification of atrophy report 3. Ophthalmology. 2018;125:537\u201348.","journal-title":"Ophthalmology"},{"key":"4331_CR19","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.ajo.2021.10.021","volume":"236","author":"AM Hagag","year":"2022","unstructured":"Hagag AM, Rasheed R, Chandra S, Jeffery G, Sivaprasad S. The diagnostic accuracy of double-layer sign in detection of macular neovascularization secondary to central serous chorioretinopathy. Am J Ophthalmol. 2022;236:271\u201380.","journal-title":"Am J Ophthalmol"},{"key":"4331_CR20","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.survophthal.2023.10.013","volume":"69","author":"A Feo","year":"2024","unstructured":"Feo A, Stradiotto E, Sacconi R, Menean M, Querques G, Romano MR. Subretinal hyperreflective material in retinal and chorioretinal disorders: A comprehensive review. Surv Ophthalmol. 2024;69:362\u201377.","journal-title":"Surv Ophthalmol"},{"key":"4331_CR21","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.ophtha.2008.12.039","volume":"116","author":"M Bolz","year":"2009","unstructured":"Bolz M, Schmidt-Erfurth U, Deak G, Mylonas G, Kriechbaum K, Scholda C, et al. Optical coherence tomographic hyperreflective foci: a morphologic sign of lipid extravasation in diabetic macular edema. Ophthalmology. 2009;116:914\u201320.","journal-title":"Ophthalmology"},{"key":"4331_CR22","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1001\/archophthalmol.2009.326","volume":"127","author":"SA Zweifel","year":"2009","unstructured":"Zweifel SA, Engelbert M, Laud K, Margolis R, Spaide RF, Freund KB. Outer Retinal Tubulation: A Novel Optical Coherence Tomography Finding. Arch Ophthalmol. 2009;127:1596\u2013602.","journal-title":"Arch Ophthalmol"},{"key":"4331_CR23","doi-asserted-by":"crossref","unstructured":"Dansingani KK, Balaratnasingam C, Naysan J, Freund KB. En face imaging of pachychoroid spectrum disorders with swept-source optical coherence tomography. Retina. 2016;36:499\u2013516.","DOI":"10.1097\/IAE.0000000000000742"},{"key":"4331_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-27078-x","volume":"13","author":"A Selvam","year":"2023","unstructured":"Selvam A, Singh SR, Arora S, Patel M, Kuchhal A, Shah S, et al. Pigment epithelial detachment composition indices (PEDCI) in neovascular age-related macular degeneration. Sci Rep. 2023;13:68.","journal-title":"Sci Rep"},{"key":"4331_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/eye.2016.208","volume":"31","author":"M Gemenetzi","year":"2017","unstructured":"Gemenetzi M, Lotery AJ, Patel PJ. Risk of geographic atrophy in age-related macular degeneration patients treated with intravitreal anti-VEGF agents. Eye. 2017;31:1\u20139.","journal-title":"Eye"},{"key":"4331_CR26","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ophtha.2013.08.015","volume":"121","author":"JE Grunwald","year":"2014","unstructured":"Grunwald JE, Daniel E, Huang J, Ying G-s, Maguire MG, Toth CA, et al. Risk of geographic atrophy in the comparison of age-related macular degeneration treatments trials. Ophthalmology. 2014;121:150\u201361.","journal-title":"Ophthalmology"},{"key":"4331_CR27","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/S0140-6736(13)61501-9","volume":"382","author":"U Chakravarthy","year":"2013","unstructured":"Chakravarthy U, Harding SP, Rogers CA, Downes SM, Lotery AJ, Culliford LA, et al. Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial. Lancet. 2013;382:1258\u201367.","journal-title":"Lancet"},{"key":"4331_CR28","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.ophtha.2014.11.007","volume":"122","author":"JE Grunwald","year":"2015","unstructured":"Grunwald JE, Pistilli M, Ying G-s, Maguire MG, Daniel E, Martin DF, et al. Growth of geographic atrophy in the comparison of age-related macular degeneration treatments trials. Ophthalmology. 2015;122:809\u201316.","journal-title":"Ophthalmology"},{"key":"4331_CR29","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s00417-024-06721-5","volume":"263","author":"K Kataoka","year":"2025","unstructured":"Kataoka K, Gale R, Li X, \u015eermet F, Qian CX, Cheung CMG, et al. Simultaneous GA and CNV\/MNV: incidence, characteristics, and treatments. Graefe\u2019s Arch Clin Exp Ophthalmol. 2025;263:1197\u2013212.","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"key":"4331_CR30","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.1038\/s41433-023-02497-w","volume":"37","author":"SS Patel","year":"2023","unstructured":"Patel SS, Lally DR, Hsu J, Wykoff CC, Eichenbaum D, Heier JS, et al. Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial. Eye. 2023;37:3551\u20137.","journal-title":"Eye"},{"key":"4331_CR31","doi-asserted-by":"publisher","first-page":"945","DOI":"10.3390\/medicina60060945","volume":"60","author":"J Ong","year":"2024","unstructured":"Ong J, Zarnegar A, Selvam A, Driban M, Chhablani J. The complement system as a therapeutic target in retinal disease. Medicina. 2024;60:945.","journal-title":"Medicina"},{"key":"4331_CR32","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.ophtha.2021.02.025","volume":"128","author":"CC Wykoff","year":"2021","unstructured":"Wykoff CC, Rosenfeld PJ, Waheed NK, Singh RP, Ronca N, Slakter JS, et al. Characterizing new-onset exudation in the randomized phase 2 FILLY trial of complement inhibitor pegcetacoplan for geographic atrophy. Ophthalmology. 2021;128:1325\u201336.","journal-title":"Ophthalmology"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04331-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04331-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04331-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T08:29:19Z","timestamp":1778488159000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04331-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["4331"],"URL":"https:\/\/doi.org\/10.1038\/s41433-026-04331-5","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]},"assertion":[{"value":"31 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}